ETOR vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

ETOR

56.3
AI Score
VS
ETOR Wins

HIVE

48.2
AI Score

Investment Advisor Scores

ETOR

56score
Recommendation
HOLD

HIVE

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ETOR HIVE Winner
Forward P/E 9.8232 62.8931 ETOR
PEG Ratio 0 0 Tie
Revenue Growth -24.6% 73.5% HIVE
Earnings Growth 87.1% -99.9% ETOR
Tradestie Score 56.3/100 48.2/100 ETOR
Profit Margin 2.2% -98.5% ETOR
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ETOR 1M: -17.8% · 3M: -23.5% HIVE 1M: -4.7% · 3M: -21.3%

Current Technical Phase

ETOR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.2%), weak momentum, RSI 37

RSI (14): 37.5 · Price: $30.31

HIVE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.9 · Price: $3.03

Fundamentals Snapshot

Metric ETOR HIVE
Market Cap
Forward P/E 10.1 -5.9
Trailing P/E 10.3
Revenue (TTM)
Revenue Growth -0.2% 0.7%
Gross Margin 0.0% 0.4%
Operating Margin 0.0% -0.6%
EPS 2.89 -1.54
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ETOR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.